Ligand validation:3PGS

LDA: LAURYL DIMETHYLAMINE-N-OXIDE

LDA is a Ligand Of Interest in 3PGS designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3PGS_LDA_A_436	33%	85%	0.154	0.931	0.27	0.47	-	-	0	0	44%	1
3PGS_LDA_B_430	31%	82%	0.133	0.865	0.27	0.53	-	-	2	0	63%	1
3PGS_LDA_A_435	28%	87%	0.184	0.939	0.27	0.42	-	-	0	0	44%	1
3PGS_LDA_A_431	27%	83%	0.177	0.88	0.27	0.51	-	-	0	0	69%	1
3PGS_LDA_A_433	21%	83%	0.165	0.82	0.28	0.49	-	-	3	0	75%	1
3PGS_LDA_A_434	12%	81%	0.266	0.862	0.24	0.57	-	-	1	0	63%	1
3PGS_LDA_A_432	11%	82%	0.232	0.818	0.27	0.52	-	-	1	0	63%	1
3PGS_LDA_A_437	10%	84%	0.176	0.748	0.27	0.49	-	-	0	0	63%	1
3PGS_LDA_B_429	10%	81%	0.285	0.852	0.27	0.55	-	-	1	0	63%	1
3PF1_LDA_A_525	33%	75%	0.176	0.92	0.42	0.54	-	-	0	0	63%	1
2R4N_LDA_B_502	20%	18%	0.328	0.934	2.14	1.4	1	3	12	0	100%	1
2R4L_LDA_B_503	20%	18%	0.307	0.912	2.19	1.4	1	1	10	0	100%	1
3DWN_LDA_B_506	13%	57%	0.289	0.871	0.53	1.1	-	1	1	0	75%	1
2R4O_LDA_A_501	10%	18%	0.323	0.833	1.94	1.6	1	3	3	0	100%	1
2VQI_LDA_B_1639	100%	35%	0.04	0.995	2.08	0.52	1	-	3	0	100%	1
6PRC_LDA_H_701	97%	23%	0.047	0.959	2.52	0.69	2	-	0	0	100%	1
3PRC_LDA_H_701	95%	24%	0.049	0.954	2.42	0.76	2	-	0	0	100%	1
2PRC_LDA_M_701	95%	25%	0.048	0.95	2.43	0.69	2	-	0	0	100%	1
5PRC_LDA_H_701	95%	20%	0.052	0.954	2.65	0.78	2	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.